Literature DB >> 15219837

Contribution of bone-marrow-derived cells to choroidal neovascularization.

Hidenori Takahashi1, Yasuo Yanagi, Yasuhiro Tamaki, Kimimasa Muranaka, Tomohiko Usui, Masataka Sata.   

Abstract

We investigated the involvement of bone-marrow derived cells to experimental choroidal neovascularization (CNV) in mice, whose bone marrow was reconstituted by either unfractionated bone-marrow cells or Lin-c(-)Kit(+)Sca-1+ enriched presumable hematopoietic stem cells from the green fluorescent protein (GFP) transgeneic mice. Immunohistochemical analysis demonstrated the presence of GFP-positive cells in the CNV lesion after unfractionated bone-marrow transplantation, as well as Lin-c(-)Kit(+)Sca-1+ cell transplantation. Some of the GFP-expressing cells also expressed CD-31 and PanEC antigen, markers of vascular endothelial cells. Our results suggest that bone-marrow derived cells may contribute endothelial cells in CNV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219837     DOI: 10.1016/j.bbrc.2004.05.177

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions.

Authors:  Hui-Yuan Hou; Hong-Liang Liang; Yu-Sheng Wang; Zhao-Xia Zhang; Bai-Ren Wang; Yuan-Yuan Shi; Xiao Dong; Yan Cai
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

2.  Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody.

Authors:  Gao-Qin Liu; Pei-Rong Lu; Long-Biao Li; Xue-Guang Zhang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

3.  Aberrant kinetics of bone marrow-derived endothelial progenitor cells in the murine oxygen-induced retinopathy model.

Authors:  Yoshihiro Nakagawa; Haruchika Masuda; Rie Ito; Michiru Kobori; Mika Wada; Tomoko Shizuno; Atsuko Sato; Takahiro Suzuki; Kenji Kawai; Takayuki Asahara
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-03       Impact factor: 4.799

Review 4.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

5.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Authors:  Vincent Lambert; Julie Lecomte; Sylvain Hansen; Silvia Blacher; Maria-Luz Alvarez Gonzalez; Ingrid Struman; Nor Eddine Sounni; Eric Rozet; Pascal de Tullio; Jean Michel Foidart; Jean-Marie Rakic; Agnès Noel
Journal:  Nat Protoc       Date:  2013-10-17       Impact factor: 13.491

6.  Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.

Authors:  Gaoqin Liu; Peirong Lu; Longbiao Li; Hui Jin; Xuefei He; Naofumi Mukaida; Xueguang Zhang
Journal:  Mol Vis       Date:  2011-08-10       Impact factor: 2.367

Review 7.  Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction.

Authors:  Natalie Jia Ying Yeo; Ebenezer Jia Jun Chan; Christine Cheung
Journal:  Front Pharmacol       Date:  2019-11-29       Impact factor: 5.810

8.  Mingjing granule, a traditional Chinese medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trial.

Authors:  Yamin Li; Lina Liang; Torkel Snellingen; Kai Xu; Yun Gao; Fengmei Zhang; Chengwei Guo; Tao Zuo; Fengming Liang; Xiaoping Yao; Xueyan Yang
Journal:  Trials       Date:  2021-01-19       Impact factor: 2.279

9.  An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.

Authors:  Hong Li; Yu-sheng Wang
Journal:  Mol Vis       Date:  2013-05-29       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.